Breast cancer
IMPACT Breast (Principal Investigator: dr. C.W. Menke-van der Houven van Oordt)
Towards patient tailored cancer treatment supported by molecular imaging - IMPACT: IMaging PAtients for Cancer drug selecTion - Metastatic Breast Cancer.
PALM (Principal Investigator: L. Buffart)
Physical Activity Levels in patients with Mammacarcinoma (PALM) study
SUBITO (Principal Investigator: dr. I.R.H.M. Konings)
Substantially improving the cure rate of highrisk BRCA1-like breast cancer patients with personalized therapy (SUBITO) an international randomized phase III trial.
SONIA trial (Principal Investigator: dr. I.R.H.M. Konings)
Selecting the Optimal PositioN of CDK4/6 Inhibitors in HR+ Advanced Breast Cancer: the SONIA trial.
AIPAC (Principal Investigator: dr. C.W. Menke-van der Houven van Oordt)
A multicentre, phase IIb, randomised, double blind, placebo-controlled study in hormone receptor-positive metastatic breast carcinoma patients receiving IMP321 (LAG-3lg fusion protein) or placebo as adjunctive to a standard chemotherapy treatment regimen of paclitaxel.